Form 4 for DERM Journey Medical Corp
Accepted 2025-08-26 00:00:00 ET · period of report 2025-08-25 · accession 0001104659-25-083217 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-26 | 2025-08-25 | DERM | Maraoui Claude | Pres, CEO, Dir | M - OptEx | $0.07 | +1.25M | 2.40M | +109% | +$87.5K |
| D | 2025-08-26 | 2025-08-25 | DERM | Maraoui Claude | Pres, CEO, Dir | F - Tax | $7.47 | -10.9K | 2.39M | -0.5% | -$81.3K |
| D | 2025-08-26 | 2025-08-25 | DERM | Maraoui Claude | Pres, CEO, Dir | M - OptEx | $0.00 | -1.25M | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.0001 par value | 2025-08-25 | M | A | 1,250,000 | $0.07 | 2,397,590 | D | — | — | (F1) Due to administrative error, the number of non-derivative securities beneficially owned by the reporting person was incorrectly reported as 2,397,590 instead of 1,147,590 on a Form 4 filed on June 20, 2025. This column reflects the corrected balance, as effected by the transactions reported on this Form 4. |
| 2 | Common | Common Stock, $0.0001 par value | 2025-08-25 | F | D | 10,877 | $7.47 | 2,386,713 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-08-25 | M | D | 1,250,000 | $0.00 | 0 | D | $0.07 · — to 2025-10-19 | 1,250,000 Common Stock, $0.0001 par value | (F2) On October 19, 2015, the reporting person was granted 1,250,000 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that vested in accordance with the following schedule: 412,500 shares on January 7, 2016, 250,000 shares on September 22, 2016, 337,500 shares on January 7, 2017 and 250,000 shares on September 22, 2017. The 1,250,000 stock options are due to expire on October 19, 2025. Accordingly, the reporting person is exercising the stock options within the 60 days prior to the expiration date. |